UiPath (PATH) Valuation Check After Recent Share Price Weakness And Automation Growth Expectations

Why UiPath is on investors’ radar right now

UiPath (PATH) has been drawing attention after recent share price moves, with the stock closing at US$12.59. Investors are weighing that level against the company’s current fundamentals and recent return profile.

See our latest analysis for UiPath.

The recent 1 day share price return of 5% decline and 7 day share price return of 14.9% decline add to a 30 day share price return of 23.2% decline. The 1 year total shareholder return of 11.5% decline and 3 year total shareholder return of 25.6% decline suggest momentum has been fading over both shorter and longer horizons as investors reassess growth expectations and risk around UiPath’s automation story.

If UiPath’s recent weakness has you reassessing your tech exposure, it could be a useful time to scan high growth tech and AI stocks for other automation and AI names on your radar.

With UiPath trading at US$12.59, some investors are eyeing its roughly 29% intrinsic discount and 30% gap to analyst targets. The key question is whether this signals a genuine opportunity or if the market already reflects future growth.

Most Popular Narrative: 23.2% Undervalued

UiPath’s most followed narrative points to a fair value of $16.40, which sits well above the current $12.59 share price and anchors a constructive automation thesis.

New product launches such as Agent Builder and Agentic Orchestration, along with strategic partnerships like with Microsoft and Deloitte, are positioned to expand market opportunities, potentially increasing earnings through higher-value deals.

Read the complete narrative.

For readers curious about what kind of revenue profile and margin lift that growth roadmap is built around, and how it feeds into a discounted cash flow at a single digit rate, the full narrative spells out the numbers behind that $16.40 fair value and the earnings power it assumes for UiPath’s automation platform.

Result: Fair Value of $16.40 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story could change quickly if deal delays tied to geopolitics worsen or if the SaaS shift and FX headwinds weigh more heavily on revenue and margins.

Find out about the key risks to this UiPath narrative.

Another View on UiPath’s valuation

That 23.2% discount to fair value uses a forward looking narrative. If you instead look at today’s P/E of 29.3x, UiPath screens as expensive versus its fair ratio of 14.3x and the US Software industry on 28x, though cheaper than peers at 46.2x. Is the market pricing in too much, or not enough?

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own UiPath Narrative

If you see the numbers differently or prefer to stress test the assumptions yourself, you can build a fresh UiPath view in minutes, starting with Do it your way.

A great starting point for your UiPath research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If UiPath is only one piece of your watchlist, now is the time to widen your search and pressure test fresh ideas before the next move in markets.

• Spot early stage opportunities by scanning these 3531 penny stocks with strong financials that pair lower share prices with balance sheets and fundamentals you can actually assess.
• Lean into the AI trend with these 25 AI penny stocks that focus on companies tied directly to automation, machine learning and related growth themes.
• Hunt for potential mispricings using these 868 undervalued stocks based on cash flows and compare what the numbers say against the expectations already baked into current prices.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com